Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (181-190 of 421) with videos related to

Pageof 43
Sort By:
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifierAdam R Brentnall, Natasa Vasiljevic, Dorota Scibior-Bentkowska, et al.
The American Journal of Surgical Pathology|January 21, 2015
The Interpretive Variability of Cervical Biopsies and Its Relationship to HPV StatusMark H Stoler, Brigitte M Ronnett, Nancy E Joste, et al.
International Journal of Cancer|March 3, 2010
Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam)Melissa Kerkhof, Monique J Roobol, Jack Cuzick, et al.
British Journal of Cancer|November 23, 2020
A case-control study to evaluate the impact of the breast screening programme on mortality in EnglandRoberta Maroni, Nathalie J Massat, Dharmishta Parmar, et al.
Familial Cancer|April 24, 2017
General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national surveySamuel G Smith, Robbie Foy, Jennifer McGowan, et al.
The American Journal of Surgical Pathology|December 12, 2018
Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of ImmunohistochemistryLuis Beltran, Amar S Ahmad, Holly Sandu, et al.
The Lancet. Digital Health|July 10, 2024
A prognostic and predictive computational pathology immune signature for ductal carcinoma in situ: retrospective results from a cohort within the UK/ANZ DCIS trialHaojia Li, Arpit Aggarwal, Paula Toro, et al.
BJU International|March 10, 2007
International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patientsGreg L Shaw, Peter Wilson, Jack Cuzick, et al.
Journal of Medical Genetics|October 30, 2016
The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control studyD Gareth Evans, Adam Brentnall, Helen Byers, et al.
Breast Cancer Research : BCR|April 6, 2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyKatja Lundgren, Matthew Brown, Silvia Pineda, et al.
Pageof 43

Showing results (181-190 of 421) with videos related to

Sort By:
Pageof 43
Cancer Biomarkers : Section a of Disease Markers|September 26, 2015
HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifierAdam R Brentnall, Natasa Vasiljevic, Dorota Scibior-Bentkowska, et al.
The American Journal of Surgical Pathology|January 21, 2015
The Interpretive Variability of Cervical Biopsies and Its Relationship to HPV StatusMark H Stoler, Brigitte M Ronnett, Nancy E Joste, et al.
International Journal of Cancer|March 3, 2010
Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam)Melissa Kerkhof, Monique J Roobol, Jack Cuzick, et al.
British Journal of Cancer|November 23, 2020
A case-control study to evaluate the impact of the breast screening programme on mortality in EnglandRoberta Maroni, Nathalie J Massat, Dharmishta Parmar, et al.
Familial Cancer|April 24, 2017
General practitioner attitudes towards prescribing aspirin to carriers of Lynch Syndrome: findings from a national surveySamuel G Smith, Robbie Foy, Jennifer McGowan, et al.
The American Journal of Surgical Pathology|December 12, 2018
Histopathologic False-positive Diagnoses of Prostate Cancer in the Age of ImmunohistochemistryLuis Beltran, Amar S Ahmad, Holly Sandu, et al.
The Lancet. Digital Health|July 10, 2024
A prognostic and predictive computational pathology immune signature for ductal carcinoma in situ: retrospective results from a cohort within the UK/ANZ DCIS trialHaojia Li, Arpit Aggarwal, Paula Toro, et al.
BJU International|March 10, 2007
International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patientsGreg L Shaw, Peter Wilson, Jack Cuzick, et al.
Journal of Medical Genetics|October 30, 2016
The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control studyD Gareth Evans, Adam Brentnall, Helen Byers, et al.
Breast Cancer Research : BCR|April 6, 2012
Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC studyKatja Lundgren, Matthew Brown, Silvia Pineda, et al.
Pageof 43